Battling Legionella: Bacteria's Role in Infection Control
Research reveals how certain bacteria fight Legionella species effectively.
Alessio Cavallaro, Silke Probst, Tobias Duft, Max Rieder, Oliver Abo El Fateh, Josch Stricker, Marco Gabrielli, Serina Robinson, Frederik Hammes
― 6 min read
Table of Contents
Legionella bacteria are sneaky little troublemakers that can be found in water. They can cause a serious illness called Legionnaires’ disease, which is becoming more common around the world. The most notorious of the group is Legionella pneumophila, which is responsible for over 90% of cases. There's a whole party of over 70 other Legionella species, some of which can also cause illness in people. While we know a lot about L. pneumophila, not much attention is given to its less famous cousins.
These bacteria tend to hang out in places like building plumbing systems and cooling towers. Unfortunately, they can be pretty hard to get rid of because they have some clever tricks up their sleeves, like forming protective layers known as biofilms and teaming up with other tiny creatures called protists.
Bacteria to the Rescue
In recent years, people have been looking for potential bacteria superheroes that can fight against Legionella. Some scientists divided these heroes into five groups based on where they come from. They include proteins from other organisms, tiny pieces of proteins that are made in labs, antimicrobial peptides (which are like bacteria's secret weapons), essential oils (yes, the same stuff in aromatherapy), and substances called Biosurfactants (think of them as bacteria's version of soap).
However, many of these compounds were discovered in labs and may not actually work in the real world where Legionella thrives.
A Competition of Bacteria
Researchers have taken things a step further by testing how well other bacteria from water sources can battle Legionella. One study looked at 80 bacteria from tap water and found that about half could slow down at least one of the Legionella strains. Other studies found similar results, where certain bacteria were pitted against Legionella and had varying degrees of success.
Interestingly, the winners of most of these battles were mainly from the Pseudomonas family. These bacteria are well-known for producing all sorts of substances that can hinder their neighbors, including Legionella.
But here's the catch: while we know some bacteria can stop L. pneumophila, we don’t know much about how they deal with other types of Legionella. It’s like focusing on a single superhero movie while ignoring all the other characters in the universe.
Our Mission
In this study, we decided to find more bacteria that could take a stand against Legionella and see how they would perform against different Legionella species. We collected water samples from various locations in Switzerland and looked for bacteria that could help us out.
We aimed to:
- Find bacteria that can inhibit Legionella growth.
- Figure out how well different Legionella species respond to these Antagonistic bacteria.
- Search for any genetic tools these bacteria might have to produce compounds that could help in the fight.
Gathering Bacteria
We collected water samples in special bottles and plated them on various growth mediums to see who could grow. After letting them chill for a few days, we picked out distinct colonies and grew them in liquid form to save for later use.
For Legionella, we used a reference strain to standardize our tests. This strain came from a German collection of microorganisms, and we also acquired other known Legionella strains from Switzerland.
The Spot-On-Lawn Assay
To evaluate the effectiveness of the bacteria we isolated, we used a method called spot-on-lawn assays. Here’s how it works: We grew Legionella on agar plates, then added our antagonistic bacteria to see if they could stop Legionella from growing. If they did, we would see clear zones around the bacteria where Legionella couldn't grow.
We found several isolates that could inhibit different strains of Legionella. We noted that some bacteria were more successful than others, and we also kept track of how effective each antagonist was.
Genome Analysis
Next, we took a closer look at the genomes of our chosen bacteria using advanced sequencing techniques. By examining their DNA, we could identify potential compounds that might explain how these bacteria inhibited Legionella.
We discovered a treasure trove of genetic clusters in the bacteria's genomes related to various compounds. One significant find was something called Non-Ribosomal-Peptide (NRP) biosynthetic gene clusters, which are often responsible for creating powerful antimicrobial compounds.
Among these compounds, we found a strong interest in a substance called viscosin. This is a lipopeptide produced by some Pseudomonas species, and it's known to have antimicrobial properties.
Testing for Success
To check if the compounds were present in the supernatants of our co-cultured bacteria, we performed liquid-liquid extraction. This process helps separate the substances produced by our bacteria, so we could analyze them further.
During our analysis using liquid chromatography and mass spectrometry, we confirmed that viscosin and other related compounds were indeed present. This was a significant breakthrough because it indicated that viscosin could be a major player in inhibiting Legionella.
Targeting Legionella
As we examined the antagonistic behavior of our bacteria, we found a variety of inhibition patterns against different Legionella species. Some antagonists were really good at stopping specific strains, while others had a broader range. For instance, L. anisa, a Legionella species, was particularly vulnerable to several of our antagonists. On the other hand, some strains of L. pneumophila had mixed results when exposed to the same antagonists.
This variability suggests that different Legionella species may have adapted to resist certain bacteria, while remaining susceptible to others. It’s a bit like a game of dodgeball where some players can dodge certain throws while others are easily hit.
Lessons Learned
Our research highlighted the importance of looking at the diversity of both Legionella and the bacteria that inhibit them. The interactions among these microbial players can tell us a lot about their roles in the environment.
Moreover, our findings support the idea that biosurfactants like viscosin could be valuable tools in the fight against Legionella. These compounds have the potential to offer a more eco-friendly alternative to traditional chemical disinfectants, especially in places like cooling towers and plumbing systems.
While more research is needed to understand how these interactions unfold in real-world settings, our findings are a step forward in unraveling the mysteries of Legionella and its antagonists.
Conclusion
In the end, we discovered that many bacteria can inhibit different Legionella species, but the results vary. This highlights the need for further research into how Legionella species interact with other microorganisms. We also identified viscosin, a promising candidate for future studies as an eco-friendly strategy for controlling Legionella in various aquatic environments.
With a bit of humor, we can liken the fight between good bacteria and Legionella to a soap opera where heroes and villains constantly vie for the spotlight. Who knew bacteria could be so intriguing? The microbial world is full of drama and potential, and we’re just scratching the surface!
In the end, we can take away the message that nature has its own ways of keeping the balance, and by studying these interactions, we can learn to harness them for the greater good.
Title: Variable inhibition of different Legionella species by antagonistic bacteria
Abstract: The genus Legionella includes opportunistic pathogens inhabiting engineered aquatic ecosystems, where managing their presence and abundance is crucial for public health. In these environments, Legionella interact positively or negatively with multiple members of the microbial communities. Here, we identified bacteria and compounds with Legionella-antagonistic properties. We isolated 212 bacterial colonies from various water sources in Switzerland and screened them for their ability to inhibit one reference strain of L. pneumophila. Ten selected antagonistic isolates were subsequently tested with spot-on-lawn-assays for inhibition towards seven environmental and two clinical isolates of Legionella, representing different species and strains. The antagonists produced highly variable inhibition patterns, highlighting distinct differences in susceptibility among Legionella species, and even strains. Only three isolates, all identified as Pseudomonas lurida, inhibited all Legionella species. Furthermore, we analysed the genomes of the antagonistic bacteria, and identified genes for several probable inhibitory compounds. We specifically found the gene cluster for the biosurfactant viscosin to be uniquely encoded by three Pseudomonas lurida isolates. This compound was subsequently detected in the supernatant of co-cultures inoculated with the antagonists and Legionella. This study provides new insights on the ability of aquatic microorganisms to compete with Legionella in controlled laboratory settings. It also highlights the diversity across and within Legionella species in their resistance to external antagonistic stress, and confirms the anti-Legionella activity of selected biosurfactants. These results can contribute to the understanding of how different species inhabit separate niches in the environment, and expand the discussion around alternative Legionella mitigation strategies.
Authors: Alessio Cavallaro, Silke Probst, Tobias Duft, Max Rieder, Oliver Abo El Fateh, Josch Stricker, Marco Gabrielli, Serina Robinson, Frederik Hammes
Last Update: 2024-11-29 00:00:00
Language: English
Source URL: https://www.biorxiv.org/content/10.1101/2024.11.27.625680
Source PDF: https://www.biorxiv.org/content/10.1101/2024.11.27.625680.full.pdf
Licence: https://creativecommons.org/licenses/by-nc/4.0/
Changes: This summary was created with assistance from AI and may have inaccuracies. For accurate information, please refer to the original source documents linked here.
Thank you to biorxiv for use of its open access interoperability.